T cell-mediated antigen presentation: A potential mechanism of infectious tolerance

Immunologic Research

Volumn 23, Issue 1, 2001, Pages 1-21

  Mannie, M D ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Antigen presentation; Autoimmunity; Immunoregulation; MHC; T cell receptor; T lymphocytes

Indexed keywords

GLYCOPROTEIN; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADOPTIVE TRANSFER; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; APOPTOSIS; CYTOKINE PRODUCTION; DESENSITIZATION; ENCEPHALOMYELITIS; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE DIFFERENTIATION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0035010040     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/ir:23:1:01     Document Type: Review

References (120)

1. Thymus and autoimmunity: Capacity of the normal thymus to produce pathogenic self-reactive T cells and conditions required for their induction of autoimmune disease
2. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance
3. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells
4. Establishment of tissue-specific tolerance is driven by regulatory T cells selected by thymic epithelium
5. Evidence for a thymus-dependent form of tolerance that is not based on elimination or anergy of reactive T cells
6. Acquired thymic tolerance and experimental allergic encephalomyelitis in the rat. I. Parameters and analysis of possible mechanisms
7. Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide
8. Thymus requirement and antigen dependency in the "infectious" tolerance pathway in transplant recipients
9. A modification of receptor theory
10. Variant TCR ligands: New insights into the molecular basis of antigen-dependent signal transduction and T-cell activation
11. High- and low-potency ligands with similar affinities for the TCR: The importance of kinetics in TCR signaling
12. From TCR engagement to T cell activation: A kinetic view oft cell behavior
13. Cross-linking and conformational change in T-cell receptors: Role in activation and in repertoire selection
14. Responses of T cells to ligands for the T-cell receptor
15. Qualitative and quantitative differences in T cell receptor binding of agonist and antagonist ligands
16. Guanine nucleotide-mediated inhibition of opioid agonist binding. Modulatory effects of ions and of receptor occupancy
17. Dopamine receptor binding on intact cells. Absence of a high-affinity agonist-receptor binding state
18. T cell receptor antagonist peptides induce positive selection
19. Positive and negative thymocyte selection
20. Influence of the affinity of selecting ligands on T cell positive and negative selection and the functional maturity of the positively selected T cells
21. The agonist-antagonist balance in positive selection
22. The nature of the peptide/MHC ligand involved in positive selection
23. Selecting and maintaining a diverse T-cell repertoire
24. +thymocytes
25. Specificity and flexibility in thymic selection
26. b: Conversion of helper-independent to helper-dependent CTL
27. Expression of major histocompatibility complex class I antigens at low levels in the thymus induces T cell tolerance via a non-deletional mechanism
28. Influence of antigen density on degree of clonal deletion in T cell receptor transgenic mice
29. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction
30. Deletion of autospecific T cells in T cell receptor (TCR) transgenic mice spares cells with normal TCR levels and low levels of CD8 molecules
31. + thymocytes: A model based on T-cell receptor avidity
32. Autologous rat myelin basic protein is a partial agonist that is converted into a full antagonist upon blockade of CD4. Evidence for the integration of efficacious and nonefficacious signals during T cell antigen recognition
33. The CD8 beta polypeptide is required for the recognition of an altered peptide ligand as an agonist
34. Role of TCR specificity in CD4 versus CD8 lineage commitment
35. Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a bcl-2 transgene
36. + T cells in lymphopenic hosts
37. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery
38. Peripheral T cell survival
39. T-cell development: A role for self-peptides in positive selection
40. Antigen-induced coreceptor down-regulation on thymocytes is not a result of apoptosis
41. Mature murine B and T cells transferred to SCID mice can survive indefinitely and many maintain a virgin phenotype
42. +T cells, but affect their long-term life span
43. Survival of mature CD4 T lymphocytes is dependent on major histocompatibility complex class II-expressing dendritic cells
44. Targeted complementation of MHC class II deficiency by intrathymic delivery of recombinant adenoviruses
45. Positive selection of extrathymically developed T cells by self-antigens
46. Differential requirements for survival and proliferation of CD8 naive or memory T cells
47. Designing and maintaining the mature TCR repertoire: The continuum of self-peptide: Self-MHC complex recognition
48. Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules
49. Balancing immunity and tolerance: Deleting and tuning lymphocyte repertoires
50. Peripheral selection of the T cell repertoire
51. Levels of peripheral T cell tolerance induced by different doses of tolerogen
52. Distinct mechansms of extrathymic T cell tolerance due to differential expression of self antigen
53. +T cells can persist and function in vivo
54. + T cell deletion
55. Fas and the art of lymphocyte maintenance
56. + thymic precursor
57. bcl-2 transgenic Lpr mice show profound enhancement of lymphadenopathy
58. An unusual lineage of alpha/beta T cells that contains automactive cells
59. + T cells creates double-negative cells in vivo
60. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand
61. Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides
62. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling
63. Inhibition of TCR triggering by a spectrum of altered peptide ligands suggests the mechanism for TCR antagonism
64. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells
65. Th2 cell clonal anergy as a consequence of partial activation
66. Microbial epitopes act as altered peptide ligands to prevent experimental autoimmune encephalomyelitis
67. A T cell receptor antagonist peptide induces T cells that mediate by stander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens
68. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein
69. In vivo antagonism of a T cell response by an endogenously expressed ligand
70. +) T cell responses to a selfpeptide
71. MHC-linked immune response suppression mediated by T cells bearing I-A- encoded determinants
72. An Ia-positive mouse T-cell clone is functional in presenting antigen to other T cells
73. Expression of Ia antigens in a murine T-lymphoma variant
74. Functional studies on the role of I-A molecules expressed by the antigen-specific T suppressor cell clone HF1
75. Fc-receptors, Ia-antigens, and immunoglobulin on normal and activated mouse T lymphocytes
76. I-A antigens on cloned alloreactive murine T lymphocytes are acquired passively
77. Detection of Ia alloantigens on phytohemagglutinin-stimulated T blast cells
78. Murine thymocyte and splenocyte Ia antigens are indistinguishable by two-dimensional gel electrophoresis
79. + BK-BI2.6.C6 T cells function as accessory cells presenting protein antigens to long-term-cultured antigen-specific T cell lines
80. Cell surface appearance of unexpected host MHC determinants on thymocytes from radiation bone marrow chimeras
81. Ly and Ia antigen phenotypes oft cells involved in delayed-type hypersensitivity and in suppression
82. Co-expression of CD4 and CD8 molecules and de novo expression of MHC class II antigens on activated rat T cells
83. + blastoid T cells showing marked upregulation of CD4, class I and II MHC, and IL2 receptor molecules is required for the expression of potent encephalitogenicity
84. Synthesis and cell surface display of class II determinants by long-term propagated rat T line cells
85. Antigen presentation in the rat: Role of a non-adherent, nonphagocytic, W3/13, OX-6 positive T cell in the presentation of antigen to primed T lymphocytes
86. + radiosensitive T cell can present antigen to primed Ia- T cells
87. An MHC class II-expressing T cell clone presenting conventional antigen lacks the ability to present bacterial superantigen
88. Expression of major histocompatibility complex class II molecules in rat T cells
89. Binding of T cell receptor to major histocompatibility complex class II- peptide complexes at the single-cell level results in the induction of antigen unresponsiveness (anergy)
90. Peptide-induced proliferation and lymphokine production in human T cells in the absence of antigen-presenting cells: Role of T-cell activation state and costimulatory signals
91. Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens
92. + T-cell clones by stimulation with soluble peptides does not require cell proliferation and is accompanied by elevated IL4 production
93. Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells
94. Essential requirement for major histocompatibility complex recognition in T-cell tolerance induction
95. Presentation of autoantigen by human T cells
96. T-cell presentation of antigen requires cell-to-cell contact for proliferation and anergy induction. Differential MHC requirements for superantigen and autoantigen
97. + T cells. I. Involvement of the CD80-CD28 adhesion molecules
98. Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression
99. Induction of tolerance in freshly isolated alloreactive T cells by activated T cell stimulators is not due to the absence of CD28-B7 interaction
100. Two types of Ia-positive T cells. Synthesis and exchange of Ia antigens
101. Early signaling defects in human T cells anergized by T cell presentation of autoantigen
102. + T cells by activated T cell stimulators
103. + T-cell clones presenting and simultaneously responding to an antigen die of apoptosis
104. T cells as antigen-presenting cells
105. T cell presentation of antigen requires cell-to-cell contact for proliferation and anergy induction: Differential MHC requirements for superantigen and autoantigen
106. T cell anergy
107. Binding of T cell receptor to major histocompatibility complex class II peptide complexes at the single-cell level results in the induction of antigen unresponsiveness (anergy)
108. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules
109. Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin
110. T-helper lymphocytes specific for myelin basic protein: Low-density activation prolongs a postactivation refractory phase marked by decreased pathogenicity and enhanced sensitivity to anergy
111. Anergy-associated T cell antigen presentation. A mechanism of infectious tolerance in experimental autoimmune encephalomyelitis
112. Partial agonism elicits an enduring phase of T-cell-medicated antigen presentation
113. Class II MHC/peptide complexes on T cell antigen-presenting cells: Agonistic antigen recognition inhibits subsequent antigen presentation
114. Antigen presentation by T cells: T cell receptor ligation promotes antigen acquisition from professional antigen-presenting cells
115. -T helper cells
116. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition
117. B lymphocytes secrete antigen-presenting vesicles
118. Vesicles bearing MHC class II molecules mediate transfer of antigen from antigen-presenting cells to CD4+ T cells
119. A unified model for T cell antigen recognition and thymic selection of the T cell repertoire
120. Immunological self/nonself discrimination: Integration of self vs nonself during cognate T cell interactions with antigen-presenting cells